Zealand Pharma A/S
(NASDAQ : ZEAL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.03%38.180.9%$1130.91m
JNJJohnson & Johnson 0.52%148.770.7%$852.35m
MRKMerck & Co., Inc. 0.53%83.980.7%$651.87m
BMYBristol-Myers Squibb Co. -0.14%63.151.0%$626.36m
ABBVAbbVie, Inc. 0.44%95.101.9%$619.08m
AZNAstraZeneca Plc -1.25%55.111.2%$544.71m
LLYEli Lilly & Co. -0.41%149.841.1%$401.23m
NVSNovartis AG -0.66%84.810.2%$152.33m
GSKGlaxoSmithKline Plc -1.48%40.580.2%$132.39m
MISTMilestone Pharmaceuticals, Inc. -2.29%8.540.0%$117.37m
OPKOPKO Health, Inc. -0.57%4.8311.2%$113.92m
NVONovo Nordisk A/S -0.56%65.970.1%$70.89m
RGENRepligen Corp. -1.42%144.187.1%$68.36m
PRNBPrincipia Biopharma, Inc. -1.13%90.760.0%$57.43m
SNYSanofi -1.87%50.410.2%$54.30m

Company Profile

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.